Loading...
Prevention of allergy by virus‐like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model
BACKGROUND: In high‐risk populations, allergen‐specific prophylaxis could protect from sensitization and subsequent development of allergic disease. However, such treatment might itself induce sensitization and allergies, thus requiring hypoallergenic vaccine formulations. We here characterized the...
Saved in:
| Published in: | Allergy |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587790/ https://ncbi.nlm.nih.gov/pubmed/30035810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.13573 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|